IN THE NAME OFGODIN THE NAME OFGOD SVTS.SAYAH
All cardiac tachyarrhythmias are produced by: 1/disorders of impulse initiation :automatic 2/abnormalities of impulse conduction: re-entrant.
Clinical History and Physical Examination Patients with paroxysmal arrhythmias are most often asymptomatic at the time of evaluation. Arrhythmia-related symptoms include palpitations; fatigue; lightheadedness; chest discomfort; dyspnea; presyncope; or, more rarely, syncope.
With SVT, syncope is observed in approximately 15% of patients, usually just after initiation of rapid SVT or with a prolonged pause after abrupt termination of the tachycardia Symptoms vary with the ventricular rate, underlying heart disease, duration of SVT, and individual patient perceptions. Supraventricular tachycardia that is persistent for weeks to months and associated with a fast ventricular response may lead to a tachycardia-mediated cardiomyopathy
Diagnostic InvestigationsDiagnostic Investigations A resting 12-lead ECG An ambulatory 24-hour Holter recording Implantable loop recorders may be helpful in selected cases Exercise testing Transesophageal atrial recordings
Invasive electrophysiological investigation with subsequent catheter ablation may be used for diagnoses and therapy
SPECIFIC ARRHYTHMIASSPECIFIC ARRHYTHMIAS A. Sinus Tachyarrhythmias 1. Physiological Sinus Tachycardia 2. Inappropriate Sinus Tachycardia 3. Postural Orthostatic Tachycardia Syndrome(autonomic dysfunction) 4. Sinus Node Re-entry Tachycardia
S.TAC.
B. Atrioventricular Nodal Reciprocating Tachycardia is the most common form of PSVT. It is more prevalent in females
AVNRT
C. Focal and Nonparoxysmal Junctional Tachycardia 1. Focal Junctional Tachycar 2. Nonparoxysmal Junctional Tachycardia
J.TAC.
D. Atrioventicular Reciprocating Tachycardia (Extra Nodal Accessory Pathways) 1. Sudden Death in WPW Syndrome and Risk Stratification: The incidence of sudden cardiac death in patients with WPW syndrome: range from 0.15 to 0.39%, over 3- to 10-year follow-up
WPW
WPW
AVRT
E. Focal Atrial TachycardiasE. Focal Atrial Tachycardias F. Macro–Re-entrant Atrial Tachycardia: 1. Isthmus-Dependent Atrial Flutter 2. Non–Cavotricuspid Isthmus-Dependent Atrial Flutter G.ATRIAL FIBRILATION
AT
AFL
AF
Acute Management of Narrow QRS-Complex Tachycardia vagal maneuvers IV antiarrhythmic drugs DC SHOCK
Wide-QRS tachycardiasWide-QRS tachycardias 1. preexisting bundle branch block; 2. functional bundle branch block (tachycardia- dependent phase 3 block); 3. ventricular pre-excitation; 4. aberrancy due to sodium channel-blocking antiarrhythmic drugs. 5.VT
WQT
Acute Management of Wide QRS- Complex Tachycardia Immediate DC cardioversion is the treatment for hemodynamically unstable tachycardias For pharmacologic termination of a stable wide QRS-complex tachycardia, IV procainamide and/or sotalol are recommended Amiodarone is preferred, compared to procainamide and sotalol, in patients with impaired left ventricular (LV) function
IRREGULAR WIDE QRSIRREGULAR WIDE QRS For termination of an irregular wide QRS-complex tachycardia (ie, pre-excited AF), DC cardioversion is recommended. If the patient is hemodynamically stable, pharmacologic conversion using IV ibutilide, flecainide, or procainamide is appropriate.
AF + LBBBAF + LBBB
First degree avbFirst degree avb
Second degree avbSecond degree avb
CHB
PVC
VT
VF
THANKS FOR YOUR ATTENTIONTHANKS FOR YOUR ATTENTION